ASAP Trial retweeted
Congratulations all @ACTA_org #TrialOfTheYearAward recipients and nominees.
Special congratulations to Trial
Of The Year winner @DrTrishaPeel and the @asap_trial based at @MonashSTM!
Practice changing infectious diseases research @ASIDANZ @AlfredHealth
nejm.org/doi/full/10.1056/NE…
The ASAP Trial has won 2024 @ACTA_org Trial of the year! Congratulations to @DrTrishaPeel and the entire @asap_trial team!
Read the results of the ASAP Trial in @NEJM nej.md/3S4XNVU
Thank you to all the sites involved, and to the @nhmrc for funding ASAP!
ASAP Trial retweeted
Don't miss out! There's still time to register & catch @DrTrishaPeel present this evening's @MonashCCS Annual Public Lecture
Register to attend online: bit.ly/49AUBaD
Register to attend in-person: bit.ly/46aSnfh
We invite you to join CALIPSO CPI Prof Trisha Peel (@DrTrishaPeel) as she presents the @MonashCCS Annual Public Lecture on Tues 21 Nov, 6-7pm AEDT
Register to attend online: bit.ly/49AUBaD
Register to attend in-person: bit.ly/46aSnfh
ASAP CPI Prof Trish Peel is presenting the 2023 @MonashCCS Annual Public Lecture on Nov 21.
She will discuss translating evidence into national and international strategies to prevent postoperative wound infections.
Follow the links below to register and tune in! #IDXposts
We invite you to join CALIPSO CPI Prof Trisha Peel (@DrTrishaPeel) as she presents the @MonashCCS Annual Public Lecture on Tues 21 Nov, 6-7pm AEDT
Register to attend online: bit.ly/49AUBaD
Register to attend in-person: bit.ly/46aSnfh
2
247
ASAP Trial retweeted
Cefazolin vs. cefazolin plus vancomycin before total hip or knee arthroplasty: jwat.ch/3Q1J4YT @NEJM
ASAP Trial retweeted
Original Article: Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty (ASAP trial) nej.md/3S4XNVU
Interested in the results of the ASAP Trial? Watch the recording of our webinar here ➡️ t.ly/pGVSv
Catch the full presentation + Q&A with our expert panel @DrTrishaPeel, Prof Allen Cheng (@peripatetical), Prof Richard de Steiger, Dr David Daly & Prof Tomas Corcoran
🔥🔥 ASAP RCT 🔥🔥 @NEJM
The addition of vancomycin to cefazolin prophylaxis was not superior to placebo for the prevention of SSIs in arthroplasty among patients without known MRSA colonization
⬆SSI with combo after TKA
⬇AKI with Vanco/CFZ
#IDXposts
nejm.org/doi/full/10.1056/NE…
Didn't catch the ASAP trial results webinar live? Watch the recording here ➡️ t.ly/pGVSv
Listen to the full presentation + Q&A with our expert panel - CPI @DrTrishaPeel, Prof Allen Cheng (@peripatetical), Prof Richard de Steiger, Dr David Daly & Prof Tomas Corcoran
1
59
ASAP Trial retweeted
Very excited to see our ASAP Trial published in The New England Journal of Medicine @NEJM. This trial would not have been possible without the dedicated orthopaedic surgeons, anaesthetists, research staff and patients. Grateful to NHMRC for funding this important trial @nhmrc.
Read the landmark results of the ASAP Trial now published in The New England Journal of Medicine @NEJM ➡️ nejm.org/doi/full/10.1056/NE…
Read about the ASAP Trial Results in the @GuardianAus - "Prescribing more antibiotics to patients undergoing joint replacement surgery does not prevent infections despite being a common practice..." ➡️ shorturl.at/fLS04
ASAP Trial retweeted
In this double-blind, randomized trial, vancomycin was added to cefazolin as surgical prophylaxis for arthroplasty. Surgical-site infections occurred in 4.5% of vancomycin recipients and 3.5% of placebo recipients. Full results of the ASAP trial: nej.md/3S4XNVU
ASAP Trial retweeted
🔥🔥 ASAP RCT 🔥🔥 @NEJM
The addition of vancomycin to cefazolin prophylaxis was not superior to placebo for the prevention of SSIs in arthroplasty among patients without known MRSA colonization
⬆SSI with combo after TKA
⬇AKI with Vanco/CFZ
#IDXposts
nejm.org/doi/full/10.1056/NE…
Read the landmark results of the ASAP Trial now published in The New England Journal of Medicine @NEJM ➡️ nejm.org/doi/full/10.1056/NE…
Webinar panelists Prof Allen Cheng (@peripatetical), Prof Trisha Peel (@DrTrishaPeel), Prof Richard de Steiger, Dr David Daly and moderator Prof Tomas Corcoran (@Tomundoc) with a live Q&A on the ASAP results
Prof Richard de Steiger discusses joint replacement outcomes. Knee and hip replacements are ⬆️ globally. Post-surgery infections occur in up to 6% of patients & result in high patient morbidity and mortality and add an extra $97 million to Australian healthcare costs...
Chief Principal Investigator @DrTrishaPeel reveals the results of the ASAP Trial - the addition of vancomycin did not protect against infection and may have led to more infections and more adverse reactions for the patients






















